Thu, Apr 17, 2014, 11:49 AM EDT - U.S. Markets close in 4 hrs 11 mins

Recent

% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • beavertail_splash beavertail_splash Mar 7, 2013 11:36 PM Flag

    CDC director Dr. Tom Frieden warns of nightmare bacteria.

    Each year, hospital-acquired infections sicken about 1.7 million and kill 99,000 people in the United States. While up to 50% of patients with CRE bloodstream infections die, similar antibiotic-susceptible bacteria kill about 20% of bloodstream-infected patients, called carbapenem-resistant Enterobacteriaceae or CRE, have increased over the past decade and grown resistant to even the most powerful antibiotics, according to the CDC. In the first half of 2012, 200 health care facilities treated patients infected with CRE.

    “CRE are nightmare bacteria,” CDC director Dr. Tom Frieden said in a statement. “Our strongest antibiotics don’t work and patients are left with potentially untreatable infections. Doctors, hospital leaders and public health must work together now to implement CDC’s ‘detect and protect’ strategy and stop these infections from spreading"

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
TSRX
13.63-0.05(-0.37%)Sep 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.